Intuitive Surgical, Inc. Cash and Restricted Cash
Intuitive Surgical, Inc. (ISRG) had Cash and Restricted Cash of $2.81 billion as of 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-21
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.81B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.05B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.41B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.85B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $2.81B 10-Q · filed 2026-07-21 |
| 2026-03-31 | $2.05B 10-Q · filed 2026-04-22 |
| 2025-12-31 | $3.41B 10-Q · filed 2026-07-21 |
| 2025-09-30 | $2.85B 10-Q · filed 2025-10-22 |
| 2025-06-30 | $3.45B 10-Q · filed 2026-07-21 |
| 2025-03-31 | $2.62B 10-Q · filed 2026-04-22 |
| 2024-12-31 | $2.06B 10-Q · filed 2026-07-21 |
| 2024-09-30 | $2.45B 10-Q · filed 2025-10-22 |
| 2024-06-30 | $3.07B 10-Q · filed 2025-07-23 |
| 2024-03-31 | $2.87B 10-Q · filed 2025-04-23 |
| 2023-12-31 | $2.77B 10-K · filed 2026-02-03 |
| 2023-09-30 | $3.62B 10-Q · filed 2024-10-18 |
| 2023-06-30 | $3.46B 10-Q · filed 2024-07-19 |
| 2023-03-31 | $2.17B 10-Q · filed 2024-04-19 |
| 2022-12-31 | $1.60B 10-K · filed 2026-02-03 |
| 2022-09-30 | $1.55B 10-Q · filed 2023-10-20 |
| 2022-06-30 | $1.55B 10-Q · filed 2023-07-24 |
| 2022-03-31 | $1.12B 10-Q · filed 2023-04-20 |
| 2021-12-31 | $1.31B 10-K · filed 2025-01-31 |
| 2021-09-30 | $1.36B 10-Q · filed 2022-10-21 |
| 2021-06-30 | $1.63B 10-Q · filed 2022-07-22 |
| 2021-03-31 | $1.42B 10-Q · filed 2022-04-22 |
| 2020-12-31 | $1.64B 10-K · filed 2024-01-31 |
| 2020-09-30 | $1.39B 10-Q · filed 2021-10-20 |
| 2020-06-30 | $2.05B 10-Q · filed 2021-07-21 |
| 2020-03-31 | $1.24B 10-Q · filed 2021-04-21 |
| 2019-12-31 | $1.18B 10-K · filed 2023-02-10 |
| 2019-09-30 | $984.60M 10-Q · filed 2020-10-19 |
| 2019-06-30 | $805.30M 10-Q · filed 2020-07-23 |
| 2019-03-31 | $890.70M 10-Q · filed 2020-04-17 |
| 2018-12-31 | $909.40M 10-K · filed 2022-02-03 |
| 2018-09-30 | $1.02B 10-Q · filed 2019-10-18 |
| 2018-06-30 | $1.22B 10-Q · filed 2019-07-22 |
| 2018-03-31 | $989.70M 10-Q · filed 2019-04-19 |
| 2017-12-31 | $663.20M 10-K · filed 2021-02-10 |
| 2017-09-30 | $890.00M 10-Q · filed 2018-10-22 |
| 2017-06-30 | $711.50M 10-Q · filed 2018-07-20 |
| 2017-03-31 | $723.60M 10-Q · filed 2018-04-18 |
| 2016-12-31 | $1.05B 10-K · filed 2020-02-07 |
| 2015-12-31 | $729.60M 10-K · filed 2019-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |